HSPG2 and non-small cell lung carcinoma: Patients with poor performance status (ECOG ≥ 2), NSCLC—not otherwise specified, and a PD-L1 expression of at least 1% were associated with poor OS in the multivariate analysis model in both pre- and post-treatment PLC quartile groups, regardless of adjustment.